Discontinuation report MODECATE CONCENTRATE
Report ID | 42850 |
Drug Identification Number | 00755575 |
Brand name | MODECATE CONCENTRATE |
Common or Proper name | Fluphenazine Decanoate |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | FLUPHENAZINE DECANOATE |
Strength(s) | 100MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR SUBCUTANEOUS |
Packaging size | 5 amp x 1 ml |
ATC code | N05AB |
ATC description | ANTIPSYCHOTICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-12-28 |
Remaining supply date | 2018-12-28 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Stock will be available until Dec. 31st, 2018. |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2019-01-02 | French | Compare |
v6 | 2019-01-02 | English | Compare |
v5 | 2018-03-14 | French | Compare |
v4 | 2018-03-14 | English | Compare |
v3 | 2018-03-14 | French | Compare |
v2 | 2018-03-14 | English | Compare |
v1 | 2018-03-14 | English | Compare |
Showing 1 to 7 of 7